In fact it will be quite interesting to see the age of the accounts receivables and whether any still fall into the late 2018 period - if so does that then bring into question the performance shares that were issued based on revenue from back then if those receivables get written off as bad debts? That would be quite ISXey lol.
Looking forward to reading the audited annual report.
- Forums
- ASX - By Stock
- DUB
- dub cap raise. lol
dub cap raise. lol, page-61
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DUB (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.002(4.55%) |
Mkt cap ! $42.27M |
Open | High | Low | Value | Volume |
4.5¢ | 4.7¢ | 4.5¢ | $39.57K | 860.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1495467 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 168705 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1495467 | 0.045 |
4 | 93816 | 0.044 |
1 | 60000 | 0.043 |
1 | 60000 | 0.042 |
3 | 368316 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 168705 | 5 |
0.049 | 600000 | 2 |
0.050 | 288897 | 3 |
0.051 | 140800 | 3 |
0.052 | 17000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
DUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online